orforglipron and retatrutide vs Orforglipron: Efficacy vs Scalability in Diabetes Treatment | Saurabh Agarwal posted on the topic Retatrutide yields results similar to

Innovative strategies, including advanced delivery systems, standardized formulations, and dietary modifications, are essential to enhance the bioavailability, efficacy, and safety of these compounds

But I, what would you say

When results slow or plateau Some people experience their first plateau during this window, where weight loss stalls for two to three weeks despite consistent medication use and dietary adherence

Wegovy does not have gastritis listed as a recognised adverse effect, but its mechanism of slowing gastric emptying may exacerbate pre-existing gastritis or cause gastritis-like symptoms

A study in the US published last year found no increased risk of pancreatitis and suggested the drugs may, rather, be associated with a lower lifetime risk